LIFECORE BIOMEDICAL, INC. \DE\: insider trades · United States · SEC (Form 4) Discover the full directors' dealings record of LIFECORE BIOMEDICAL, INC. \DE\, a listed equity based in United States. Shares trade on US US, under the oversight of SEC (Form 4). Market capitalisation: €178.5m. The latest transaction was disclosed on 22 May 2025 (Retenue fiscale). Among the most active insiders: Kiper Christopher S. All data is free.
€262,651
3 ops.
Sell Volume
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 22 May 2025
All Executives55 Thresholds0 Prospectus0 Other0
Declarations 55 total
● Chief Executive Officer · Executives · 20 May 2025
21,532 shares @ US$6.63 57.3% of flow Common Stock SEC:0001005286-25-000074:0
12,334 shares @ US$7.0012 29.4% of flow Common Stock SEC:0000950170-25-073196:0
5,098 shares @ US$7.0014 12.1% of flow Common Stock SEC:0000950170-25-069576:0
24,543 shares @ US$7.0827 58.5% of flow Common Stock SEC:0000950170-25-066222:0
◆ Chief Legal & Administration · Executives · 14 Apr 2025
45,000 shares Common Stock SEC:0001005286-25-000070:0
▲ Chief Executive Officer · Executives · 8 Jan 2025
17,000 shares @ US$5.74 42.7% of flow Common Stock SEC:0001628280-25-000943:0
Ideal exit: 5 Oct 2025 (T+270) ◆ Chief Financial Officer · Executives · 6 Dec 2024
19,720 shares 0Common Stock SEC:0001628280-24-050619:0
◆ Chief Executive Officer · Executives · 6 Dec 2024
38,461 shares 0Common Stock SEC:0001628280-24-050620:0
◇ Chief Financial Officer · Executives · 7 Oct 2024
75,000 shares Common Stock SEC:0001628280-24-044118:0
▲ Director · Executives · 3 Oct 2024
1,311,312 shares @ US$4.10 100.0% of flow Common Stock SEC:0000921895-24-002254:0
Ideal exit: 30 Jun 2025 (T+270) 122,930 shares @ US$4.10 14.7% of flow Common Stock, $0.001 par value per share SEC:0001104659-24-106795:0
Ideal exit: 30 Jun 2025 (T+270) ◆ Director · Executives · 19 Aug 2024
24,554 shares Common Stock SEC:0001628280-24-040456:0
◆ Chief Financial Officer · Executives · 3 Sept 2024
262,500 shares Common Stock SEC:0001628280-24-039547:0
◆ Director · Executives · 19 Aug 2024
24,554 shares Common Stock SEC:0001628280-24-038196:0
◆ Director · Executives · 19 Aug 2024
24,554 shares Common Stock SEC:0001628280-24-038088:0
◆ Director · Executives · 19 Aug 2024
24,554 shares Common Stock SEC:0001628280-24-038090:0
◆ Director · Executives · 19 Aug 2024
24,554 shares Common Stock SEC:0001628280-24-038091:0
◆ Director · Executives · 8 Jul 2024
30,000 shares Common Stock SEC:0001628280-24-031634:0
◆ Director · Executives · 8 Jul 2024
30,000 shares Common Stock SEC:0001628280-24-031626:0
◆ Director · Executives · 8 Jul 2024
30,000 shares Common Stock SEC:0000921895-24-001545:0
◆ Director · Executives · 8 Jul 2024
30,000 shares Common Stock SEC:0001628280-24-031630:0
◆ Director · Executives · 8 Jul 2024
30,000 shares Common Stock SEC:0001628280-24-031636:0
◆ Director · Executives · 8 Jul 2024
30,000 shares Common Stock SEC:0001628280-24-031628:0
◆ Director · Executives · 8 Jul 2024
30,000 shares Common Stock SEC:0001628280-24-031624:0
◆ Director · Executives · 8 Jul 2024
30,000 shares Common Stock SEC:0001628280-24-031632:0
25 of 55 declarations
Load more (30 remaining)